These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15141690)

  • 41. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perspectives. Employer Part D subsidy may slightly slow retiree-coverage decline.
    Med Health; 2005 Mar; 59(6 Spec no.):9, 15-6. PubMed ID: 17066526
    [No Abstract]   [Full Text] [Related]  

  • 43. Perspectives. Employer Part D subsidy may slightly slow retiree-coverage decline.
    Med Health; 2005 Feb; 59(7):1, 7-8. PubMed ID: 15771307
    [No Abstract]   [Full Text] [Related]  

  • 44. What the new Medicare law means to you.
    J Okla State Med Assoc; 2004 May; 97(5):197-9. PubMed ID: 15212106
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of PBMs in implementing the Medicare prescription drug benefit.
    Atlas RF
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-504-15. PubMed ID: 15513957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should you switch Medicare plans?
    Consum Rep; 2004 Sep; 69(9):51. PubMed ID: 15305428
    [No Abstract]   [Full Text] [Related]  

  • 48. Highlights of the Medicare Prescription Drug Act.
    Conomikes GS
    J Okla State Med Assoc; 2005 Oct; 98(10):492-3. PubMed ID: 16296207
    [No Abstract]   [Full Text] [Related]  

  • 49. More on Medicare Part D.
    Klein CA
    Nurse Pract; 2007 May; 32(5):16. PubMed ID: 17476157
    [No Abstract]   [Full Text] [Related]  

  • 50. What Medicare really needs.
    Quinn JB
    Newsweek; 2000 Sep; 136(13):36. PubMed ID: 11183317
    [No Abstract]   [Full Text] [Related]  

  • 51. Medicare Part D: where we are and where we're going.
    Stefanacci RG
    Manag Care; 2006 Jul; 15(7 Suppl 3):2-5. PubMed ID: 16898052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
    AVMA Group Health & Life Insurance Trust
    J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
    [No Abstract]   [Full Text] [Related]  

  • 53. HMOs' grasp on drug benefits is getting stronger.
    Traska MR
    Hospitals; 1986 Apr; 60(8):68. PubMed ID: 3957318
    [No Abstract]   [Full Text] [Related]  

  • 54. Need help understanding Medicare or Medicaid?
    Pa Health You; 2002; 105(2):12. PubMed ID: 16350776
    [No Abstract]   [Full Text] [Related]  

  • 55. A Medicare drug law has Rorschach Test features.
    Elwood TW
    J Allied Health; 2004; 33(2):89-94. PubMed ID: 15239406
    [No Abstract]   [Full Text] [Related]  

  • 56. What do the Medicare changes mean to you?
    Gonser G
    J Mass Dent Soc; 2006; 54(4):15. PubMed ID: 16536159
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Part D implementation: how did health plans fare? A conversation with Stan Nowak, founder, president, and chief executive officer of Silverlink Communications. Interview by William Atkinson.
    Nowak S
    AHIP Cover; 2006; 47(4):46, 49, 51. PubMed ID: 16894854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medicare Advantage under fire. House and Senate have overpayments in their sights.
    DoBias M
    Mod Healthc; 2007 May; 37(21):8-9. PubMed ID: 17828833
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited.
    Batata A
    J Health Econ; 2004 Sep; 23(5):951-63. PubMed ID: 15353188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.